Download Referencias - Asociación Colombiana de Endocrinología

74
Referencias
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
Lavin N. Endocrinología y Metabolismo. Quinta edición. Marban. 2003.
William RH. Tratado de endocrinología. Quinta edición. Salvat. 1983.
Greenspan FS. Endocrinología básica y clínica. Sexta edición. M.M. 2005
Felig P, Baxter JD, Frohman L (eds). Endocrinology and Metabolism, Tercera
edición. Mc Graw Hill. 1995.
Lemaire, D. (27 de mayo de 2005). eMedicine - Thyroid anatomy. Último acceso 19 de enero 2008.
Kliegman: Nelson Textbook of Pediatrics. 18th ed. Saunders, 2007. Hypothyroidism (chapter 566). Revisada en: http://www.mdconsult.com/books/page.
do?eid=4-u1.0-B978-1-4160-245.
US Preventive Services Task Force. Screening for congenital hypothyroidism:
US Preventive Services Task Force reaffirmation recommendation. Ann Fam
Med. 2008;6(2):166.
Lazarus JH. Congenital hypothyroidism. Arch Dis Child. 2005;90(2):112-3.
Yang RL, Zhu ZW, Zhou XL, Zhao ZY. Treatment and follow-up of children with
transient congenital hypothyroidism. J Zhejiang Univ Sci B. 2005;6(12):1206-9.
Escobar I. Trastornos de la función tiroidea. En: Tratado de Medicina Interna
4ª Edición 2005. Editores: Chalem, Escandón, Campos y Esguerra. Editorial
Médica Celsus, Bogotá, Colombia. Páginas 1562 a 1601
Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, Smith SA, Daniels
GH, Cohen HD. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med. 2000;160(11):1573-5.
Escobar I. Dosis de levotiroxina (T4) para el tratamiento del hipotiroidismo
primario. En: Sociedad Latinoamericana de Tiroides. Libro de Resúmenes VII
Congreso SLAT, 1997. Página 25, resumen 17.
Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228-38.
Asociación Colombiana de Endocrinología. Consenso colombiano para el diagnóstico y manejo de las enfermedades tiroideas. Acta Med Colomb 1999;
24:159-174
Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction.
Endocr Rev. 2008;29(1):76-131
De Groot L. Chapter 10. Graves´ Disease and the Manifestation of Thyrotoxicosis. In: www. THYROIDMANAGER.ORG. January 2010.
Woeber KA. Observations concerning the natural history of subclinical hyperthyroidism. Thyroid. 2005;15(7):687-91.
Trzepacz PT, Klein I, Roberts M, Greenhouse J, Levey GS. Graves’ disease: an
analysis of thyroid hormone levels and hyperthyroid signs and symptoms. Am
J Med. 1989;87(5):558-61.
Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves’ ophthalmopathy. Thyroid. 2002;12(10):855-60.
Oppo A, Franceschi E, Atzeni F, Taberlet A, Mariotti S. Effects of hyperthyroidism, hypothyroidism, and thyroid autoimmunity on female sexual function. J
Endocrinol Invest. 2011;34(6):449-53.
Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):172535.
Schultz M, Kistorp C, Raymond I, Dimsits J, Tuxen C, Hildebrandt P, Faber J. Cardiovascular events in thyroid disease: a population based, prospective study.
Horm Metab Res. 2011;43(9):653-9.
75
23. Nayak B, Hodak SP. Hyperthyroidism. Endocrinol Metab Clin North Am.
2007;36(3):617-56
24. Wiersinga WM. Should we treat mild subclinical/mild hyperthyroidism? Yes.
Eur J Intern Med. 2011;22(4):324-9
25. Abraham P, Avenell A, Watson WA, et al. Antithyroid Drug Regimen for Treating Graves´s Hyperthyroidism. 2005. Cochrane Database Syst Rev. 18: CD
0034230
26. Walter MA, Briel M, Christ-Crain M, Bonnema SJ, Connell J, Cooper DS, Bucher
HC, Müller-Brand J, Müller B. Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials.
BMJ. 2007;334(7592):514.
27. Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle P. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med.
1998;338(11):712-8.
28. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg
P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN; American
Thyroid Association; American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the
American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593-646.
29. Mazza E, Carlini M, Flecchia D, Blatto A, Zuccarini O, Gamba S, Beninati S, Messina M. Long-term follow-up of patients with hyperthyroidism due to Graves’
disease treated with methimazole. Comparison of usual treatment schedule
with drug discontinuation vs continuous treatment with low methimazole
doses: a retrospective study. J Endocrinol Invest. 2008;31(10):866-72.
30. Fitzpatrick DL, Russell MA. Diagnosis and management of thyroid disease in
pregnancy. Obstet Gynecol Clin North Am. 2010;37(2):173-93
31. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 1997;18(3):40433.
32. Burrow GN, Fisher DA, Larsen PR. Maternal and fetal thyroid function. N Engl J
Med. 1994;331(16):1072-8.
33. Glinoer D, Lemone M. Goiter and pregnancy: a new insight into an old problem. Thyroid. 1992;2(1):65-70.
34. Toldy E, Löcsei Z, Rigó E, Kneffel P, Szabolcs I, Kovács GL. Comparative analytical evaluation of thyroid hormone levels in pregnancy and in women taking
oral contraceptives: a study from an iodine deficient area. Gynecol Endocrinol.
2004;18(4):219-26.
35. Nelson M, Wickus GG, Caplan RH, Beguin EA. Thyroid gland size in pregnancy.
An ultrasound and clinical study. J Reprod Med. 1987;32(12):888-90.
36. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab.
2006;91(7):2587-91.
37. Pearce EN. Diagnosis and management of thyrotoxicosis. BMJ.
2006;332(7554):1369-73
38. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R,
Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W; American Thyroid
Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for the diagnosis and
management of thyroid disease during pregnancy and postpartum. Thyroid.
2011;21(10):1081-125.
76
39. Marx H, Amin P, Lazarus JH. Hyperthyroidism and pregnancy. BMJ.
2008;336(7645):663-7.
40. Alsanea O, Clark OH. Treatment of Graves’ disease: the advantages of surgery.
Endocrinol Metab Clin North Am. 2000;29(2):321-37.
41. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22(2):263-77.
42. Rivera R, Hernández S, Ochoa C, Rodríguez S y Torres P. Diagnóstico y tratamiento del nódulo tiroideo. Posición de la Sociedad Mexicana de Nutrición y
Endocrinología. 2009.
43. Bennedbaek FN, Perrild H, Hegedüs L. Diagnosis and treatment of the
solitary thyroid nodule. Results of a European survey. Clin Endocrinol (Oxf).
1999;50(3):357-63.
44. Gharib H, Papini E, Paschke R. Thyroid nodules: a review of current guidelines,
practices, and prospects. Eur J Endocrinol. 2008;159(5):493-505.
45. Mandel SJ. A 64-year-old woman with a thyroid nodule. JAMA.
2004;292(21):2632-42..
46. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P; AACE/
AME/ETA Task Force on Thyroid Nodules. American Association of Clinical
Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid
Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract. 2010;16 Suppl 1:1-43.
47. Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med.
2004;351(17):1764-71.
48. Gharib H, Papini E, Valcavi R, Baskin HJ, Crescenzi A, Dottorini ME, Duick DS,
Guglielmi R, Hamilton CR Jr, Zeiger MA, Zini M; AACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2006;12(1):63-102.
49. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules
and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos
RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid
cancer. Thyroid. 2009;19(11):1167-214.
50. Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG,
Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer.
American Thyroid Association. Arch Intern Med. 1996;156(19):2165-72.
51. Hegedüs L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev. 2003;24(1):102-32.
52. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and
treatment. Endocrinol Metab Clin North Am. 2007;36(3):707-35.
53. Fish SA, Langer JE, Mandel SJ. Sonographic imaging of thyroid nodules and
cervical lymph nodes. Endocrinol Metab Clin North Am. 2008;37(2):401-17.
54. Layfield LJ, Cibas ES, Gharib H, Mandel SJ. Thyroid aspiration cytology: current
status. CA Cancer J Clin. 2009;59(2):99-110.
55. Papanicolau Society of Cytopathology Recommendations for Thyroid Fine
Needle Aspiration. www.papsociety.org/guidelines.html.
56. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri
EL, McIver B, Sherman SI, Tuttle RM; American Thyroid Association Guidelines
Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16(2):109-42.
77
57. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Globocan 2008,
Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]. 58 Lyon: International Agency for Research on Cancer; 2010. Disponible
en: http://globocan.iarc.fr.
58. Colombia, Instituto Nacional de Cancerología. Datos estadísticos. Bogotá: INC;
noviembre de 2009.
59. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri
EL, McIver B, Sherman SI, Tuttle RM; American Thyroid Association Guidelines
Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16(2):109-42.
60. DeLellis R, Lloyd R, Heitz P, Eng C. Pathology and genetics of tumours of endocrine organs. World Health Organization Classification of Tumours. IARC Press;
Lyon 2004. p. 48-127.
61. Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell
neoplasia. Nat Rev Cancer. 2006;6(4):292-306.
62. Garavito G, Llamas A, Cadena E , De Los Reyes A , Romero A, Hurtado G, Rojas
L Martínez C Mejía c , De Francisco J. Manejo multidisciplinario del cáncer
diferenciado de tiroides en el Instituto Nacional de Cancerología. Revista Colombiana de Cancerología 2010; 14(2) 65-77
63. Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen
BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis M, Maxon HR, Sherman SI. Outcomes of patients with differentiated thyroid carcinoma following
initial therapy. Thyroid. 2006;16(12):1229-42.
64. Ronga G, Filesi M, Ventroni G, Vestri AR, Signore A. Value of the first serum
thyroglobulin level after total thyroidectomy for the diagnosis of metastases
from differentiated thyroid carcinoma. Eur J Nucl Med. 1999;26(11):1448-52.
65. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS, Nicoloff JT. Serum thyroglobulin autoantibodies: prevalence,
influence on serum thyroglobulin measurement, and prognostic significance
in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab.
1998;83(4):1121-7.
66. Mazzaferri EL, Kloos RT. Is diagnostic iodine-131 scanning with recombinant
human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab. 2002;87(4):1490-8.
67. Mazzaferri EL. Empirically treating high serum thyroglobulin levels. J Nucl Med.
2005;46(7):1079-88.
68. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules
and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos
RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid
cancer. Thyroid. 2009;19(11):1167-214.
69. Baudin E, Schlumberger M. New therapeutic approaches for metastatic thyroid carcinoma. Lancet Oncol. 2007;8(2):148-56.
70. The Washington manual-Subspeciality consult series- Endocrinología consulta
de la subespecialidad-segunda edicion-2009. Catherine E. Henderson-Thomas
J. Baransh.
71. Niepomniszcze H, Movelli JL. Hipotiroidismo. UNR 2009.
72. Dufour DR. Laboratory tests of thyroid function: uses and limitations. Endocrinol Metab Clin North Am. 2007;36(3):579-94.
73. Albarran. Endocrinología -editorial médica panamericana, 2 edición. octubre
2010.
78
74. Leonor P, Pérez P, Medrano MH, Pruebas diagnósticas en endocrinología. Sociedad mexicana de nutrición y endocrinología -2008.
75. C.Diequez Y Turriago. Actualizaciones en endocrinología. tiroides. 2 Edición N.
3- C.R. Mc Graw Hill 2007.
76. Bverly M.k Biller MD. Clinical endocrinology: 2009 endocrine division-Mssachusetts General Hospital. Harvard Medical School, Boston April 6-8 2009
77. Cooper DS. Medical management of thyroid disease. second edition. Informa
Health Care, 2008.
78. Nystrom E.Thyroid disease in adults. Springer 2011
79. Argente Oliver J. Manual de Endocrinología Pediátrica. Editorial Ergon.
80. Brent GA. Thyroid Function Testing. Springer 2011
81. Cooper, DS. Medical Management of Thyroid Disease. Second Edition. Informa
Healthcare. 2009. 448 p.
82. Bach-Huynh TG, Nayak B, Loh J, Soldin S, Jonklaas J. Timing of levothyroxine
administration affects serum thyrotropin concentration. J Clin Endocrinol
Metab. 2009;94(10):3905-12.
83. Benvenga S, Bartolone L, Pappalardo MA, Russo A, Lapa D, Giorgianni G, Saraceno G, Trimarchi F. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301.
84. Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781-92.
85. Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH.
Replacement dose, metabolism, and bioavailability of levothyroxine in the
treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in
humans. N Engl J Med. 1987;316(13):764-70.
86. Roos A, Linn-Rasker SP, van Domburg RT, Tijssen JP, Berghout A. The starting
dose of levothyroxine in primary hypothyroidism treatment: a prospective,
randomized, double-blind trial. Arch Intern Med. 2005;165(15):1714-20.
87. Kabadi UM. Optimal daily levothyroxine dose in primary hypothyroidism.
Its relation to pretreatment thyroid hormone indexes. Arch Intern Med.
1989;149(10):2209-12.
88. Kronenberg, Melmed, Polonsky, Larsen. Williams Textbook of Endocrinology.
Edition 11. 2009.
89. Kohl BA, Schwartz S. Surgery in the patient with endocrine dysfunction. Med
Clin North Am. 2009;93(5):1031-47.